More than 10,000 patients with diabetes were given semaglutide and compared to controls, which included placebo, SGLT-2 inhibitors, and other GLP-1 agonists in the case of liraglutide
Yang X, Wu LL, Chura LR, Liang X, Lane M, Norman RJ, et al
We have recently reported indirect evidence for this model
As a tripeptide composed of glutamine, cysteine, and glycine, this reduced formalso called GSHis renowned as a master antioxidant that supports liver detoxification, immune function, and healthy cell regeneration Clinical and cosmetic applications include skin brightening, reduction of dark spots, improving skin elasticity, and minimizing wrinkles by inhibiting melanin production via tyrosinase suppression Studies have shown oral supplementation at doses of 250500 mg/day significantly improved skin tone and reduced pigmentation over 812 weeks Product Features Benefits & Uses Antioxidant Defense & Detoxification Neutralizes free radicals, protecting liver cells and supporting detox pathways Skin Brightening & Anti-aging Studies indicate 250500 mg/day oral intake over 12 weeks reduces melanin and wrinkles

In the increasingly competitive GLP-1 market, Novo Nordisk has continued to explore and expand the boundaries of Semaglutide's indications, with multiple clinical launches in NASH, AD, HFpEF, DR, PAD, and other indications